LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 929 | 2177 | 3228 | 0.6746 | 0.5431 |
Hs 578T | PF477736 | 0.37 | uM | LJP5 | 72 | hr | 929 | 1377 | 3228 | 0.4267 | 0.1949 |
Hs 578T | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2472 | 3228 | 0.7658 | 0.6711 |
Hs 578T | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 929 | 3263 | 3228 | 1.0109 | 1.0153 |
Hs 578T | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1593 | 3228 | 0.4936 | 0.2889 |
Hs 578T | PI103 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1354 | 3228 | 0.4197 | 0.1851 |
Hs 578T | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 929 | 3703 | 3228 | 1.1472 | 1.2067 |
Hs 578T | QL-X-138 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2212 | 3228 | 0.6855 | 0.5583 |
Hs 578T | QL-XII-47 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2623 | 3228 | 0.8127 | 0.7369 |
Hs 578T | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 929 | 3180 | 3228 | 0.9851 | 0.9791 |
Hs 578T | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 929 | 3006 | 3228 | 0.9313 | 0.9036 |
Hs 578T | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 929 | 3143 | 3228 | 0.9738 | 0.9631 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 3162 | 3228 | 0.9795 | 0.9713 |
Hs 578T | XL147 | 0.37 | uM | LJP5 | 72 | hr | 929 | 3202 | 3228 | 0.9920 | 0.9888 |
Hs 578T | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 2606 | 3228 | 0.8074 | 0.7295 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 1748 | 3228 | 0.5415 | 0.3562 |
Hs 578T | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 929 | 2179 | 3228 | 0.6751 | 0.5438 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3923 | 3228 | 1.2155 | 1.3026 |
Hs 578T | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 929 | 3089 | 3228 | 0.9569 | 0.9395 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2959 | 3228 | 0.9169 | 0.8833 |
Hs 578T | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 929 | 2964 | 3228 | 0.9183 | 0.8853 |
Hs 578T | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1314 | 3228 | 0.4072 | 0.1675 |
Hs 578T | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 929 | 1130 | 3228 | 0.3502 | 0.0875 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 929 | 1386 | 3228 | 0.4294 | 0.1987 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 1485 | 3228 | 0.4600 | 0.2418 |